Bristol-Myers Squibb buy UBS Group AG
Start price
07.01.26
/
50%
€47.50
Target price
07.01.27
€55.55
Performance (%)
6.93%
Price
27.03.26
€50.79
Summary
This prediction is currently active. With a performance of 6.93%, the BUY prediction by UBS_Group_AG for Bristol-Myers Squibb is trending in the right direction. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 2.451% | 2.451% |
| iShares Core DAX® | -0,48 % | -12,06 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % |
| iShares S&P 500 | -2,27 % | -5,05 % |
Comments by UBS_Group_AG for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat